1. Home
  2. WNW vs VVOS Comparison

WNW vs VVOS Comparison

Compare WNW & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meiwu Technology Company Limited

WNW

Meiwu Technology Company Limited

BUY

Current Price

$2.36

Market Cap

4.5M

ML Signal

BUY

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.16

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNW
VVOS
Founded
2018
2016
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
WNW
VVOS
Price
$2.36
$0.16
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $2.12
AVG Volume (30 Days)
49.2K
★ 2.4M
Earning Date
11-04-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.76
EPS
★ N/A
N/A
Revenue
N/A
★ $17,443,000.00
Revenue This Year
N/A
$24.92
Revenue Next Year
N/A
$56.44
P/E Ratio
$1.14
★ N/A
Revenue Growth
N/A
★ 16.05
52 Week Low
$0.05
$0.13
52 Week High
$13.52
$3.35

Technical Indicators

Market Signals
Indicator
WNW
VVOS
Relative Strength Index (RSI) 45.15 37.73
Support Level $2.30 N/A
Resistance Level $2.69 $0.55
Average True Range (ATR) 0.13 0.01
MACD 0.01 0.01
Stochastic Oscillator 11.69 54.01

Price Performance

Historical Comparison
WNW
VVOS

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: